Overview

Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza

Status:
Not yet recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of AV5080 versus Placebo based on time to symptom resolution in patients with uncomplicated influenza.
Phase:
Phase 3
Details
Lead Sponsor:
Viriom